UK researchers announced a breakthrough gene therapy that slowed Huntington’s disease for the first time. Early-stage trials at University College London showed some patients’ condition progressed 75% slower over three years. The therapy, AMT-130, is delivered via direct brain injection.
Related Posts
Russian air strikes pound Kyiv, 6-year-old boy among dead, Zelensky says
Russia launched missile and drone attacks on Kyiv on July 31, killing at least six people including a six-year-old boy…
Energia solar flutuante deve chegar a usinas hidrelétricas
O uso de placas solares no Brasil para geração de eletricidade tem crescido exponencialmente. Há instalações de pequeno e médio…
Hundreds of thousands in Gaza ‘catastrophically food insecure’
Humanitarian aid must be allowed into Gaza “at scale” by Israel to avoid a “generation of children that won’t have…